691 related articles for article (PubMed ID: 22125934)
21. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India.
Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U
Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718
[TBL] [Abstract][Full Text] [Related]
22. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
23. A study of relapse after MDT in a district in West Bengal, India.
Haldar A; Mahapatra BS; Mundle M; Haldar S; Saha AK
Indian J Lepr; 2003; 75(1):1-8. PubMed ID: 15253389
[TBL] [Abstract][Full Text] [Related]
24. Diagnosing leprosy: revisiting the role of the slit-skin smear with critical analysis of the applicability of polymerase chain reaction in diagnosis.
Banerjee S; Biswas N; Kanti Das N; Sil A; Ghosh P; Hasanoor Raja AH; Dasgupta S; Kanti Datta P; Bhattacharya B
Int J Dermatol; 2011 Dec; 50(12):1522-7. PubMed ID: 22097999
[TBL] [Abstract][Full Text] [Related]
25. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
26. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
Kaur I; Dogra S; Kumar B; Radotra BD
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological trends of leprosy in an urban leprosy centre of Delhi: a retrospective study of 16 years.
Tiwary PK; Kar HK; Sharma PK; Gautam RK; Arora TC; Naik H; Dhir V
Indian J Lepr; 2011; 83(4):201-8. PubMed ID: 22783754
[TBL] [Abstract][Full Text] [Related]
28. Clinical and epidemiological trends in childhood leprosy: A 20-year retrospective analysis from a tertiary care hospital in Jammu, North India.
Sakral A; Dogra N; Dogra D; Sharma K
Indian J Dermatol Venereol Leprol; 2022; 88(6):755-760. PubMed ID: 35146981
[TBL] [Abstract][Full Text] [Related]
29. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
Kamal R; Dayal R; Katoch VM; Katoch K
Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
[TBL] [Abstract][Full Text] [Related]
30. Leprosy in the post-elimination era: a clinico-epidemiological study from a northern Indian tertiary care hospital.
Arif T; Amin SS; Adil M; Dorjay K; Raj D
Acta Dermatovenerol Alp Pannonica Adriat; 2019 Mar; 28(1):7-10. PubMed ID: 30901062
[TBL] [Abstract][Full Text] [Related]
31. Primary neuritic leprosy: a reappraisal at a tertiary care hospital.
Mendiratta V; Khan A; Jain A
Indian J Lepr; 2006; 78(3):261-7. PubMed ID: 17120509
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
Pandey A; Uddin MJ; Patel R
Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
[TBL] [Abstract][Full Text] [Related]
33. A study on the impact of FD-MDT on 200 leprosy patients.
Vara N; Marfatiya Y
Indian J Lepr; 2005; 77(3):217-27. PubMed ID: 16353520
[TBL] [Abstract][Full Text] [Related]
34. Impact of integration on the profile of newly diagnosed leprosy patients attending a referral hospital in South India.
Daniel S; Arunthathi S; Rao PS
Indian J Lepr; 2009; 81(2):69-74. PubMed ID: 20509335
[TBL] [Abstract][Full Text] [Related]
35. Childhood leprosy in the post-elimination phase: data from a tertiary health care hospital in the Karnataka state of south India.
Palit A; Inamadar AC; Desai SS; Sharma P
Lepr Rev; 2014 Jun; 85(2):85-92. PubMed ID: 25255612
[TBL] [Abstract][Full Text] [Related]
36. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
Vijayakumaran P; Manimozhi N; Jesudasan K
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
[TBL] [Abstract][Full Text] [Related]
37. Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.
Sharma A; Sharma VK; Rajwanshi A; Das A; Kaur I; Kumar B
Lepr Rev; 1999 Sep; 70(3):281-6. PubMed ID: 10603717
[TBL] [Abstract][Full Text] [Related]
38. Correlation of clinical and histopathological classification of leprosy in post elimination era.
Bijjaragi S; Kulkarni V; Suresh KK; Chatura KR; Kumar P
Indian J Lepr; 2012; 84(4):271-5. PubMed ID: 23720892
[TBL] [Abstract][Full Text] [Related]
39. The significance of changes in the nasal mucosa in indeterminate, tuberculoid and borderline leprosy.
Chacko CJ; Bhanu T; Victor V; Alexander R; Taylor PM; Job CK
Lepr India; 1979 Jan; 51(1):8-22. PubMed ID: 376945
[TBL] [Abstract][Full Text] [Related]
40. Epidemiological characteristics of leprosy reactions: 15 years experience from north India.
Kumar B; Dogra S; Kaur I
Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):125-33. PubMed ID: 15301592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
